Quince Therapeutics, Inc. (QNCX)
1.165
-0.04
(-2.92%)
USD |
NASDAQ |
May 27, 16:00
1.17
0.00 (0.00%)
After-Hours: 19:44
Quince Therapeutics Cash from Investing (Quarterly) : 12.00M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BioXcel Therapeutics, Inc. | 0.00 |
| Gossamer Bio, Inc. | 41.61M |
| Recursion Pharmaceuticals, Inc. | -0.338M |
| Acurx Pharmaceuticals, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.627M |
| Cash from Financing (Quarterly) | 9.443M |
| Free Cash Flow | -39.66M |
| Free Cash Flow Per Share (Quarterly) | -0.8299 |
| Free Cash Flow to Equity (Quarterly) | 10.44M |
| Free Cash Flow to Firm (Quarterly) | -7.627M |
| Free Cash Flow Yield | -548.4% |